Developing Safe and Effective Covid Vaccines — Operation Warp Speed’s Strategy and Approach
New England Journal of MedicinePublished 26 August 2020
M. Slaoui, Matthew J. Hepburn
Citations219
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveWill appear once the snapshot is generated
MethodsWill appear once the snapshot is generated
PopulationWill appear once the snapshot is generated
Sample sizeWill appear once the snapshot is generated
OutcomesWill appear once the snapshot is generated
ResultsWill appear once the snapshot is generated
LimitationsWill appear once the snapshot is generated
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Operation Warp Speed’s Strategy and Approach The public–private initiative Operation Warp Speed aims to deliver tens of millions of doses of an FDA-approved SARS-CoV-2 vaccine beginning at the end ...
Keywords
Social SciencesMedicine
New England Journal of MedicineAn mRNA Vaccine against SARS-CoV-2 — Preliminary Report
3,422 Citations2020Lisa A. Jackson, Evan J. Anderson +31 more
The mRNA-1273 vaccine induced anti-SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified, which support further development of this vaccine.
The LancetSafety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
2,614 Citations2020Pedro M. Folegatti, Katie Ewer +363 more
A phase 1/2, single-blind, randomised controlled trial in five trial sites in the UK of a chimpanzee adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein compared with a meningococcal conjugate vaccine as control to assess efficacy, reactogenicity, and cellular and humoral immune responses.